Summary:

• The global connected drug delivery devices market size reached USD 864.4 Million in 2023.
• The market is expected to reach USD 6,879.9 Million by 2032, exhibiting a growth rate (CAGR) of 25.1% during 2024-2032.
• North America leads the market, accounting for the largest connected drug delivery devices market share.
• Connected sensors account for the majority of the market share in the product segment due to smooth integration with currently in-use medication delivery equipment, improving compliance and monitoring without the need for brand-new systems.
• Hospitals and healthcare hold the largest share in the connected drug delivery devices industry.
• Bluetooth remains a dominant segment in the market because of its dependability, low energy usage, and versatility with a wide array of gadgets.
• The increasing regulatory support for digital health solutions, which encourages the adoption of connected medical technologies, is aiding the market growth.
• Along with this, the growing demand for real-time data analytics in healthcare enables more precise treatment adjustments and proactive interventions based on patient medication adherence, thus supporting the market growth.

Request to Get the Sample Report: https://www.imarcgroup.com/connected-drug-delivery-devices-market/requestsample

Industry Trends and Drivers:

• The Growing Prevalence of Chronic Diseases:

The growing prevalence of chronic diseases such as diabetes, asthma, and cardiovascular disorders (CVD) is one of the key factors driving the connected drug delivery devices market. As chronic diseases require long-term and often complex medication regimens, connected devices offer a way to improve treatment adherence and monitoring.

These devices, such as smart inhalers and insulin pumps, can remind patients when to take their medication, monitor usage patterns, and share data with healthcare providers. With the rising incidence of these diseases globally, there is an increasing demand for connected devices that can provide continuous, real-time feedback to ensure better disease management and reduce hospital readmissions thus providing an impetus to the market growth.

• The Rising Demand for Patient-Centric Care:

The rising demand for patient-centric care is another significant driver of the connected drug delivery devices market. As healthcare systems shift toward value-based care models, there is a growing emphasis on improving patient outcomes and enhancing the patient experience. Connected drug delivery devices empower patients by providing them with tools to manage their treatment more effectively.

These devices enable patients to track their medication schedules, dosage levels, and side effects while also giving them the flexibility to adjust their treatments as needed in consultation with their healthcare providers. Moreover, connected devices offer greater convenience by allowing remote monitoring, reducing the need for frequent hospital visits is contributing to the market growth.

• Advancements in Digital Health Technologies:

Advancements in digital health technologies are also fueling the growth of the connected drug delivery devices market. With the development of technologies such as the Internet of Things (IoT), artificial intelligence (AI), and cloud-based platforms, connected drug delivery devices can now collect, store, and analyze vast amounts of data. This enables healthcare providers to monitor patient health remotely and make more informed decisions based on real-time data.

For example, AI algorithms can analyze medication adherence data to predict potential health risks or complications, allowing for timely interventions. The integration of these technologies and enhances the functionality of drug delivery devices facilitates seamless communication between patients and healthcare providers, strengthening the market growth.

Speak to An Analyst: https://www.imarcgroup.com/request?type=report&id=3738&flag=C

Connected Drug Delivery Devices Market Report Segmentation:

Breakup By Product:

• Connected Sensors
  • Connected Inhaler Sensors
  • Connectable Injection Sensors
• Integrated Connected Devices
  • Connected Inhalation Devices
  • Connected Injection Devices

Connected sensors account for the majority of shares because they offer seamless integration with existing drug delivery devices, enhancing monitoring and compliance without requiring entirely new systems.

Breakup By End User:

• Hospitals and Healthcare Providers
• Homecare

Hospitals and healthcare providers dominate the market as it rely on connected drug delivery devices for real-time patient data, improving treatment precision and patient outcomes.

Breakup By Technology:

• Bluetooth
• NFC
• Other Technologies

Bluetooth holds the majority of shares due to its reliability, low energy consumption, and compatibility with a broad range of devices.

Breakup By Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America holds the leading position owing to advanced healthcare infrastructure, high prevalence of chronic diseases, and early adoption of digital health technologies.

Top Connected Drug Delivery Devices Market Leaders: The connected drug delivery devices market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies.

Some of the key players in the market are:

• Adherium Ltd.
• BioCorp Production
• Cohero Health Inc. (AptarGroup Inc.)
• Elcam Medical ACS. Ltd
• Findair Sp. z o. o.
• Merck KGaA
• Phillips Medisize (Molex LLC)
• Propeller Health (Resmed Inc.)
• Teva Pharmaceutical Industries Ltd.
• West Pharmaceutical Services Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1–631–791–1145

Content Source: https://www.chat-hozn3.com/blogs/22915/Connected-Drug-Delivery-Devices-Market-Demands-Growth-Analysis-Industry-Report